What is Ocular Therapeutix's PP&E (net)?

Ocular Therapeutix (OCUL) reported PP&E (net) of $18.43M in Q1 2026.

How has Ocular Therapeutix's PP&E (net) changed year-over-year?

Ocular Therapeutix's PP&E (net) increased by 70.9% year-over-year, from $10.78M to $18.43M.

What is the long-term trend for Ocular Therapeutix's PP&E (net)?

Over 5 years (2020 to 2025), Ocular Therapeutix's PP&E (net) has grown at a 19.4% compound annual growth rate (CAGR), from $8.1M to $19.68M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Ocular Therapeutix OCUL PP&E (Net)

PP&E (Net) at other companies

Bausch + LombBLCO

$1.79B+13.5%

HRO

HarrowHROW

$3.13M-12.3%

Tarsus Pharmaceuticals, Inc.TARS

$17.67M+534%

Kodiak Sciences IncKOD

$81.51M-16.7%

Ultragenyx PharmaceuticalRARE

$239M-8.4%

PBH

Prestige Consumer HealthcarePBH

$121.69M+63.2%

Other financials

Income statement

See full

Revenue$10.8M+0.8%

Gross profit$9.5M+0.2%

Operating income-$93.3M-46.0%

Net income-$88.6M-38.3%

EPS (diluted)-$0.40-5.3%

Balance sheet

See full

Cash & equivalents$666.7M+90.7%

Total debt$79.5M+4.2%

Total equity$581.6M+119%

Total assets$732.5M+80.5%

Cash flow

See full

Operating cash flow-$66.0M-47.7%

CapEx$4.7M+141%

Free cash flow-$70.7M-51.6%

Valuation

See full

Market cap$2.21B+58.2%

Enterprise value$1.63B+40.8%

P/S42.6×+19.1×

Profitability

See full

Gross margin87.2%-3.4pp

Operating margin-575.4%+1,233pp

Net margin-558.2%+1,493pp

FCF margin-463%+2,860pp

Returns & leverage

See full

Return on equity-68.6%+17.0pp

Debt / equity0.1×-0.2×

Current ratio14.8×+4.6×

Where this comes from

Reported directly by Ocular Therapeutix in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ocular Therapeutix's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ocular Therapeutix's PP&E (net)?: Ocular Therapeutix (OCUL) reported PP&E (net) of $18.43M in Q1 2026.
How has Ocular Therapeutix's PP&E (net) changed year-over-year?: Ocular Therapeutix's PP&E (net) increased by 70.9% year-over-year, from $10.78M to $18.43M.
What is the long-term trend for Ocular Therapeutix's PP&E (net)?: Over 5 years (2020 to 2025), Ocular Therapeutix's PP&E (net) has grown at a 19.4% compound annual growth rate (CAGR), from $8.1M to $19.68M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.